Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.4150 (2.38%) ($11.4150 - $11.4150) on Fri. Dec. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 46 | Latest Price | $11.4150(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(19%) URA(17%) BLOK(16%) XLK(16%) VUG(14%) | Factors Impacting BCRX price | BCRX will decline at least -1.84% in a week (0% probabilities). SMH(-29%) ARKG(-23%) VIXM(-9%) SHY(-8%) GLD(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.97(-134.78%) | 5 Day Moving Average | $10.93(4.44%) | 10 Day Moving Average | $10.99(3.87%) | 20 Day Moving Average | $11.37(0.4%) | To recent high | -19.7% | To recent low | 9% | Market Cap | $2.014b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |